Home-grown mobile phone maker Lava International plans to invest around Rs 1,100 crore over the next five years to deepen its presence in the electronics components ecosystem by setting up ...

Start a conversation with TipRanks’ trusted, data-backed investment intelligence Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds The latest ...

Roblox Corporation (NYSE: RBLX) today announced that its Board of Directors has authorized the repurchase of up to $3 billion of the company’s common stock with the intent to buy back up to $1 billion ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

This as-told-to essay is based on a conversation with Michael Strahl, a 41-year-old senior construction technician and content creator based in Minneapolis. It has been edited for length and clarity.

AI-powered design platform Picsart is launching a creator monetization program, the company told TechCrunch exclusively. The program is open to all creators, with no invite lists and no minimum ...

Funded by grants from Apple and Microsoft, the new program helps Detroit youth learn 3D design, coding, and critical thinking skills while building their own games on ...

The Artemis program is years behind schedule and billions of dollars over budget. Could a successful mission quiet its critics? The 322-foot-tall rocket stands ready on the launch pad at the Kennedy ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. The NCAA Tournament bracket is set after Selection Sunday, but not all ...

Song IDs are key to getting the most out of music in-game. Image credit: Roblox Finding Roblox song IDs that work requires more upkeep than is ideal. Many stop working due to copyright strikes or are ...

GLP-1 weight-loss drugs have quickly become some of the most sought-after medications in the United States, but their price tags have also made them one of the most difficult benefits for employers ...